Richard D. Francis, President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 62,122 shares at $13.34 ($829K) on 2024-03-04, disclosed to the SEC on 2024-03-05.
Scheduled sale ($829k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.34 | 31,061 | $414K | 50.0% |
| 2 | $13.34 | 31,061 | $414K | 50.0% |
| Total | $13.34 avg | 62,122 | $829K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $1.5M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $28.7M | — | Filing → |
| TEVA | SELL | 2026-02-18 | $30.6M | — | Filing → |